Class-action lawsuit filed against Chicago cannabis sellers over false wellness claims
Published on May 7, 2026.
A class-action lawsuit has been filed against three Chicago-based cannabis companies for allegedly marketing products with false medical benefits. This comes after the Trump administration reclassified marijuana as a Schedule 3 substance. The lawsuit focuses on consumer protection and the public's right to know about potential side effects of high-potency THC.
Related Articles
Hantavirus ‘not COVID’: WHO official
WHO official Maria DeJoseph Van Kerkhove emphasized that the hantavirus outbreak on a cruise ship in the Atlantic Ocean is not a pandemic-like threat, emphasizing its distinct nature and close contact nature.
University of Utah expands doctor of physical therapy program
The University of Utah's Doctor of Physical Therapy program now offers three campuses, one in St. George, to strengthen its workforce for rural and underserved areas.
Passenger Aboard Hantavirus Ship Speaks Out About ‘Shock’ of Deaths on Board: ‘Deceased on the Ship for Several Days’
Irish passenger Ann Lane describes the shock and subsequent deaths of passengers on the MV Hondius cruise ship, amid a suspected hantavirus outbreak.